CNTX — Context Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareMicro Cap
Annual cashflow statement for Context Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.5 | -14.8 | -24 | -26.7 | -36.1 |
| Depreciation | |||||
| Non-Cash Items | 3.88 | 1.55 | 1.13 | 15.6 | 3.44 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.22 | -0.278 | 1.78 | -3.48 | 6.28 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -8.8 | -13.5 | -21 | -14.6 | -26.4 |
| Capital Expenditures | — | -0.037 | 0 | -0.007 | -0.034 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.25 | -0.5 | 0 | -14.8 | -2 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.25 | -0.537 | 0 | -14.8 | -2.03 |
| Financing Cash Flow Items | — | -0.102 | 0 | 94.8 | -0.015 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 58.4 | -0.102 | 0 | 109 | -0.015 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 49.3 | -14.2 | -21 | 80 | -28.4 |